| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,690 |
3,972 |
$198K |
| 84443 |
Thyroid stimulating hormone (TSH) |
10,297 |
9,063 |
$178K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,875 |
6,077 |
$165K |
| 80061 |
Lipid panel |
11,581 |
10,219 |
$161K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,065 |
17,009 |
$141K |
| 80053 |
Comprehensive metabolic panel |
11,943 |
10,360 |
$131K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,209 |
1,991 |
$112K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,147 |
4,184 |
$111K |
| 86738 |
|
5,163 |
4,619 |
$64K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,180 |
1,844 |
$58K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,800 |
5,025 |
$57K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
950 |
890 |
$48K |
| 86702 |
|
3,007 |
2,564 |
$34K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,035 |
901 |
$34K |
| 82274 |
|
2,456 |
2,280 |
$33K |
| 86701 |
|
3,650 |
3,204 |
$30K |
| 81001 |
|
9,603 |
9,111 |
$26K |
| 86328 |
|
1,274 |
1,185 |
$26K |
| 84439 |
|
2,956 |
2,391 |
$24K |
| 82607 |
|
1,711 |
1,393 |
$24K |
| 82043 |
|
3,477 |
2,963 |
$18K |
| 86592 |
|
4,177 |
3,766 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
4,739 |
3,180 |
$14K |
| 84153 |
|
889 |
856 |
$14K |
| 87088 |
|
1,662 |
1,428 |
$14K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
407 |
319 |
$13K |
| 81000 |
|
2,941 |
1,770 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,244 |
1,138 |
$10K |
| 84436 |
|
1,465 |
1,337 |
$9K |
| 84479 |
|
1,177 |
1,060 |
$7K |
| 87400 |
|
283 |
280 |
$6K |
| 87581 |
|
130 |
123 |
$4K |
| 85027 |
|
677 |
619 |
$4K |
| 82951 |
|
274 |
259 |
$3K |
| 82570 |
|
555 |
346 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
344 |
321 |
$2K |
| 86703 |
|
217 |
214 |
$2K |
| 80074 |
|
39 |
17 |
$2K |
| 82952 |
|
271 |
257 |
$2K |
| 85651 |
|
445 |
340 |
$2K |
| 87590 |
|
78 |
69 |
$2K |
| 86769 |
|
38 |
37 |
$1K |
| 85610 |
|
354 |
219 |
$1K |
| 84703 |
|
154 |
146 |
$1K |
| 86038 |
|
85 |
53 |
$968.92 |
| 86803 |
|
65 |
39 |
$931.02 |
| 85730 |
|
162 |
116 |
$862.36 |
| 82947 |
|
232 |
224 |
$779.97 |
| 83655 |
|
61 |
59 |
$720.29 |
| 87899 |
|
39 |
32 |
$532.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
64 |
60 |
$501.17 |
| 87084 |
|
19 |
13 |
$361.41 |
| 86140 |
|
78 |
55 |
$358.10 |
| 85652 |
|
92 |
90 |
$234.40 |
| 87186 |
|
28 |
24 |
$227.04 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
46 |
40 |
$216.38 |
| 87077 |
|
27 |
24 |
$211.82 |
| 84550 |
|
45 |
15 |
$202.12 |
| 86706 |
|
14 |
13 |
$140.02 |
| 84481 |
|
13 |
13 |
$128.29 |
| 87071 |
|
16 |
14 |
$113.79 |
| 87177 |
|
17 |
14 |
$82.99 |
| 84156 |
|
27 |
27 |
$66.90 |
| 84460 |
|
13 |
13 |
$41.65 |
| 84450 |
|
13 |
13 |
$40.66 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
321 |
306 |
$0.44 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,655 |
1,134 |
$0.00 |